Sign inJoin waitlistJoin the waitlist

Frank C. Passero

Associate Professor - Department of Medicine, Hematology/Oncology · URochester Medicine

Credentials: · · · · · ·

History

URochester Medicine
Present

Tufts Medical Center
2014–2017
Scripps Mercy Hospital San Diego
2011–2014
Scripps Mercy Hospital San Diego
2010–2011
Thomas Jefferson University Hospital
2010

Research

The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy
Review · Expert Review of Anticancer Therapy · 2016 · First of 4 authors · 102 citations
Ostomy telehealth for cancer survivors: Design of the Ostomy Self-management Training (OSMT) randomized trial
Contemporary Clinical Trials · 2018 · 49 citations
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma
Cancer Research · 2016 · 34 citations

Andrew Evens
4 papers
KD
Kevin David
3 papers
Robert Krouse
3 papers
RW
Ronald Weinstein
3 papers
Bruce Goldman
2 papers
Justin Komisarof
2 papers · 2 as a resident
Amit Chowdhry
1 paper · 1 as a resident
Andrew Portuguese
1 paper · 1 as a resident
AK
Athena Kritharis
1 paper · 1 as a fellow
Brea Lipe
1 paper
Chauncey Syposs
1 paper · 1 as a fellow
Conrad Gleber
1 paper · 1 as a resident

Clinical trials

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
Principal investigator · Active not recruiting · Phase 2
University of Rochester
2021–2027
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2024–2030